Issue 10-26-2009
Related
Public option still alive as health care reform advances
A little over a week after the Senate Finance Committee passed a health care reform bill without a public insurance plan, that option appears to be back on the table. “At the end of the day we will have a public option,” House Speaker Nancy Pelosi told reporters in response to questions about
Duane Reade makes statement in beauty
Duane Reade Inc. has staked its claim to the luxury beauty market. The drug chain’s just-opened 24-hour store in Manhattan’s Herald Square features its new Look Boutique with prestige brands in high-end displays.
Walgreens provides a ‘food oasis’
Walgreen Co. has become an oasis in the “food desert” here. The chain has bulked up its food offerings in two Chicago stores to meet the needs of residents underserved by grocers, and it plans to do the same in nine other outlets in the city, mostly on the south side. If the
Rexall achieves success thinking outside the box
As drug chains across North America continue to evolve, many are exploring new ways to expand their business going forward. At the Katz Group’s Rexall chain, that has meant putting a greater emphasis on health care and delivering cost-effective solutions for businesses.
Latest
Cardinal Health expands Actinium-225 production capacity to support growing demand for novel cancer therapies
Move to support growing demand for novel cancer therapies
Nature Made and Avo team to launch new collab: From Supplements to SuperGreens Bowls
The limited time offering will be available at all four New York Avo locations and online starting today, March 31st through June 30th.
Current Health taps Cardinal Health to scale hospital-at-home
This collaboration helps health systems simplify operations, lower program costs, and reduce vendor complexity so their programs can grow more sustainably.
Bayer announces leadership change within Pharmaceuticals’ Worldwide Markets organization in the U.S.
Nelson Ambrogio, currently president of Bayer’s global Radiology business, will be appointed president of Bayer U.S. Pharmaceuticals.